Ming-He Huang

Exceptional survival of a patient with large ventricular septal defect, bidirectional shunt, and severe pulmonary valve stenosis.

Images in cardiology: a coronary-left ventricular fistula associated with myocardial ischemia.

Cardiac syndrome X.

Modulation of angiotensin II responses in sympathetic neurons by cytosolic calcium.

Postural position and neurocardiogenic syncope in late pregnancy.

Idiopathic Brugada-type electrocardiographic pattern in an octogenarian.

Mechanisms of angiotensin II-mediated decreases in intraneuronal Ca2+ in calcium-loaded stellate ganglion neurons.

Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2.

Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.

Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions.

An unusual complication after aortic valve replacement.

Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat.

Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.

Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin.

Mediating delta-opioid-initiated heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cell.

Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination.

The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation.

The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation.

Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2.

Reducing ischaemia/reperfusion injury through delta-opioid-regulated intrinsic cardiac adrenergic cells: adrenopeptidergic co-signalling.

Trypanosoma cruzi infection disturbs mitochondrial membrane potential and ROS production rate in cardiomyocytes.

Cardiac calcitonin gene-related peptide and left ventricular hypertrophy in the cardiac allograft.

Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion.

Delta-opioid augments cardiac contraction through β-adrenergic and CGRP-receptor co-signaling.